49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

26 trials found

diseases per page:

Showing 1 to 10 of 26 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05666336 (ClinicalTrials.gov)	December 31, 2022	8/12/2022	Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients	Proteomics Combined With Metabolomics Studies on the Efficacy of Telitacicept in Chinese Patients of ...	Systemic Lupus Erythematosus	Biological: Telitacicept;Drug: Hydroxychloroquine;Drug: Prednisone;Drug: Methylprednisolone;Drug: Cy ...	Fen Li	NULL	Not yet recruiting	18 Years	75 Years	All	30	Phase 4	NULL
2	NCT04702256 (ClinicalTrials.gov)	December 9, 2021	30/11/2020	Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticoste ...	Induction Therapy for Lupus Nephritis With no Added Oral Steroids: An Open Label Randomised Multicen ...	Lupus Nephritis;Systemic Lupus Erythematosus (SLE)	Drug: Obinutuzumab administration;Drug: Administration of Methylprednisolone + Prednisone+ Mycophenol ...	Assistance Publique - Hôpitaux de Paris	Roche Pharma AG	Recruiting	14 Years	N/A	All	196	Phase 3	France
3	ChiCTR2100048635	2021-07-19	2021-07-12	The Impact of low-dose prednisonewithdrawal on disease flare and organ damage in SLE patients: a ran ...	The Impact of low-dose prednisonewithdrawal on disease flare and organ damage in SLE patients: a ran ...	Systemic Lupus Erythematosus	Withdrawal group:withdraw low dose prednisone;maintanence group:maintain low dose prednisone;	Peking University First Hospital	NULL	Pending			Both	Withdrawal group:92;maintanence group:92;		China
4	ChiCTR1900022934	2019-06-20	2019-05-04	Study for the metabolic mechanism of Langchuangjing granule in the treatment of systemic lupus eryth ...	Study for the metabolic mechanism of Langchuangjing granule in the treatment of systemic lupus eryth ...	Systemic Lupus Erythematosus	Experimental group:Langchuangjing granule + Prednisone acetatetablets, Hydroxychloroquine;control gro ...	Nanjing University of Chinese Medicine Affiliated Hospital	NULL	Pending			Both	Experimental group:20;control group:20;healthy control group:20;	Phase 1	China
5	ITMCTR1900002316	2019-06-20	2019-05-04	Study for the metabolic mechanism of Langchuangjing granule in the treatment of systemic lupus eryth ...	Study for the metabolic mechanism of Langchuangjing granule in the treatment of systemic lupus eryth ...	Systemic Lupus Erythematosus	healthy control group:nothing;control group:Prednisone acetatetablets\Hydroxychloroquine;Experimental ...	Nanjing University of Chinese Medicine Affiliated Hospital	NULL	Pending			Both	healthy control group:20;control group:20;Experimental group:20;	Phase 1	China
6	NCT03804723 (ClinicalTrials.gov)	June 2019	11/1/2019	Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus	Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus: a Randomized Placebo-controlled Eq ...	Systemic Lupus Erythematosus;Glucocorticoids;Therapy Withdrawal	Drug: oral Prednisone 5mg	University of Pisa	NULL	Not yet recruiting	18 Years	85 Years	All	321	N/A	NULL
7	ChiCTR1800020286	2019-02-01	2018-12-22	Clinical evaluation of the application of Langchuangjing granule in the treatment of systemic lupus ...	Efficacy and safety of Langchuangjing granule in the treatment of systemic lupus erythematosus: a cl ...	Systemic Lupus Erythematosus	Group 2:Langchuangjing granule + Prednisone acetatetablets, hydroxychloroquineand other Western medic ...	Nanjing University of Chinese Medicine Affiliated Hospital	NULL	Pending			Both	Group 2:40;Group 1:20;	I (Phase 1 study)	China
8	ChiCTR1800017540	2018-09-01	2018-08-03	A randomized controlled trial for the long-term outcomes of MMF on new onset SLE patients with high ...	A randomized controlled trial for the long-term outcomes of MMF on new onset SLE patients with high ...	systemic lupus erythematosus	1:Hydroxychloroquine(5mg/kg/day) plus prednisone(0.5mg/kg/day);2:Hydroxychloroquine(5mg/kg/day) plus ...	Ruijin Hospital	NULL	Completed	18	65	Both	1:65;2:65;	Phase 4	China
9	NCT03492255 (ClinicalTrials.gov)	April 12, 2018	16/3/2018	CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid	CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid	Systemic Lupus Erythematosus (SLE)	Drug: Cyclophosphamide;Drug: Methylprednisolone;Drug: Prednisone;Drug: Mycophenolate Mofetil	University of Sao Paulo General Hospital	Fundação de Amparo à Pesquisa do Estado de São Paulo	Terminated	18 Years	N/A	All	49	N/A	Brazil
10	NCT03098823 (ClinicalTrials.gov)	September 12, 2017	21/3/2017	A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE	A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of ...	Lupus Erythematosus, Systemic;Lupus Erythematosus;Fatigue	Drug: RAYOS;Drug: Prednisone	Ampel BioSolutions, LLC	NULL	Completed	18 Years	99 Years	All	62	Phase 4	United States

First Previous1 2 3Next Last